Bio-Rad (BIO) Laboratories announced the launch of four new Droplet Digital PCR platforms, including its QX Continuum system and the QX700 series platforms acquired as part of its recent acquisition of Stilla Technologies. The expanded product portfolio, including over 400K assays, offers a comprehensive line of digital PCR products for life science research and diagnostic applications. Executive VP Jim Barry stated the launch strengthens Bio-Rad’s leadership in droplet digital PCR solutions.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BIO: